Kairos Pharma Investor Relations Material
Latest events
Q4 2024
2 Jun, 2025
Q3 2024
13 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Kairos Pharma Ltd
Access all reports
Kairos Pharma Ltd is a biopharmaceutical company focused on the development of cancer therapies. The company is engaged in researching and advancing novel treatments targeting various types of cancer through immunotherapy, targeted therapy, and combination approaches. The company is headquartered in Los Angeles, California, and its shares are listed on the OTC markets.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
KAPA
Country
🇺🇸 United States